Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$4.40
+0.200 (+4.76%)
At Close: May 08, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0858 $8.83 Wednesday, 8th May 2024 ATXI stock ended at $4.40. This is 4.76% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 13.73% from a day low at $4.15 to a day high of $4.72.
90 days $0.0858 $8.83
52 weeks $0.0858 $8.83

Historical Avenue Therapeutics, Inc. prices

Date Open High Low Close Volume
Dec 13, 2023 $0.152 $0.153 $0.138 $0.142 901 149
Dec 12, 2023 $0.144 $0.159 $0.135 $0.154 1 648 251
Dec 11, 2023 $0.153 $0.153 $0.130 $0.136 2 023 810
Dec 08, 2023 $0.153 $0.158 $0.141 $0.154 1 164 839
Dec 07, 2023 $0.175 $0.175 $0.140 $0.155 2 542 861
Dec 06, 2023 $0.171 $0.175 $0.161 $0.170 1 603 217
Dec 05, 2023 $0.188 $0.188 $0.168 $0.170 2 188 575
Dec 04, 2023 $0.190 $0.203 $0.182 $0.184 2 688 497
Dec 01, 2023 $0.190 $0.211 $0.180 $0.192 4 334 508
Nov 30, 2023 $0.200 $0.218 $0.170 $0.212 15 264 850
Nov 29, 2023 $0.300 $0.325 $0.173 $0.174 70 527 679
Nov 28, 2023 $0.199 $0.199 $0.175 $0.188 965 674
Nov 27, 2023 $0.190 $0.195 $0.177 $0.186 283 776
Nov 24, 2023 $0.200 $0.209 $0.180 $0.188 265 395
Nov 22, 2023 $0.198 $0.200 $0.180 $0.185 182 349
Nov 21, 2023 $0.201 $0.203 $0.190 $0.196 119 873
Nov 20, 2023 $0.200 $0.210 $0.195 $0.201 240 862
Nov 17, 2023 $0.200 $0.201 $0.187 $0.200 166 993
Nov 16, 2023 $0.200 $0.200 $0.180 $0.196 110 077
Nov 15, 2023 $0.202 $0.202 $0.180 $0.190 195 794
Nov 14, 2023 $0.205 $0.205 $0.182 $0.199 186 751
Nov 13, 2023 $0.223 $0.223 $0.195 $0.197 431 731
Nov 10, 2023 $0.228 $0.230 $0.200 $0.225 187 841
Nov 09, 2023 $0.240 $0.240 $0.216 $0.230 135 841
Nov 08, 2023 $0.225 $0.236 $0.220 $0.230 174 088
Click to get the best stock tips daily for free!

About Avenue Therapeutics, Inc.

Avenue Therapeutics. Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.... ATXI Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT